Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Cancer care is undergoing a radical transformation as new technologies move toward personalized medicine. This text by Springer examines the most dramatic advances in the field: therapeutics that augment the immune response to tumors. Readers will explore the development and clinical application of immune checkpoint inhibitors, which represent the most advanced examples of immune therapeutics targeting tumor cells. The content covers foundational treatments such as approved antibody drugs directed at cell surface proteins CTLA4 and PD-1. These therapies are now essential for several solid tumor indications. This book provides a deep look into how drug development is changing the landscape of oncology through targeted immune responses.